Evidence map›Paper›PMID 33088353›Full record

ArticleNuclear medicine and molecular imaging2020

Evaluating Focal

Ayşegül Aksu, Nazlı Pınar Karahan Şen, Emine Acar, Gamze Çapa Kaya

Abstract read
In one paragraph

Article in Nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Quantitative classification and radiomics of [European journal of nuclear medicine and molecular imaging · 2022
    Trial
  3. Article
  4. Article
  5. Applying deep learning-based ensemble model to [Japanese journal of radiology · 2025
    Article
  6. Clinical application ofJapanese journal of radiology · 2024
    Review
  7. PrognosticDiagnostics (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Radiomics Analysis of [Diagnostics (Basel, Switzerland) · 2022
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayşegül AksuDepartment of Nuclear Medicine, School of Medicine, Dokuz Eylul University, İzmir, Turkey.ORCID 0000-0002-6239-0660
Nazlı Pınar Karahan ŞenDepartment of Nuclear Medicine, School of Medicine, Dokuz Eylul University, İzmir, Turkey.
Emine AcarDepartment of Nuclear Medicine, Kent Hospital, İzmir, Turkey.
Gamze Çapa KayaDepartment of Nuclear Medicine, School of Medicine, Dokuz Eylul University, İzmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to evaluate the ability of

methods

resultsSixty patients (70% train set, 30% test set) were included in the study. In univariate analysis, a statistically significant difference was observed in 6 conventional parameters, 5 first-, and 16 second-order features between benign and malignant groups in train set (

conclusionIn the differentiation of benign-malignant thyroid incidentalomas, GLRLM

Indexed as

FDGPETRadiomicsTextureThyroid incidentaloma

Identifiers

PMID33088353
PMCPMC7560675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.